ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ARCT Arcturus Therapeutics Holdings Inc

26.98
-0.95 (-3.40%)
Apr 24 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Arcturus Therapeutics Holdings Inc ARCT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.95 -3.40% 26.98 20:00:00
Open Price Low Price High Price Close Price Prev Close
28.20 26.585 28.38 26.98 27.93
more quote information »

Recent News

Date Time Source Heading
3/07/202416:05EDGAR2Form 8-K - Current report
3/07/202416:01BWArcturus Therapeutics Announces Fourth Quarter and Fiscal..
2/26/202409:00BWArcturus Therapeutics to Present at the Barclays 26th Annual..
2/23/202416:05EDGAR2Form 8-K - Current report
2/22/202408:30BWArcturus Therapeutics Receives Orphan Medicinal Product..
2/20/202409:00BWArcturus Therapeutics to Report Fourth Quarter and Full Year..
2/05/202408:30PRNUSNew COVID-19 sa-mRNA Results from CSL and Arcturus..
12/21/202308:00PRNUSCSL and Arcturus Therapeutics' ARCT-154 Demonstrates..
12/19/202320:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/04/202308:30BWArcturus Therapeutics to Present at the 42nd Annual J.P...
11/28/202308:05PRNUSJapan's Ministry of Health, Labour and Welfare Approves CSL..
11/28/202308:00BWJapan's Ministry of Health, Labour and Welfare Approves CSL..
11/27/202309:13DJNArcturus Therapeutics Gets FDA Orphan Designation for..
11/27/202308:30BWArcturus Therapeutics Receives Orphan Drug Designation from..
11/15/202308:51IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Analyst..
11/14/202316:10EDGAR2Form 8-K - Current report
11/14/202316:01BWArcturus Therapeutics Announces Third Quarter 2023 Financial..
10/25/202316:01BWArcturus Therapeutics to Report Third Quarter Financial..
10/23/202316:01BWArcturus Therapeutics to Attend Upcoming Investor &..
10/04/202308:30BWArcturus Therapeutics Joint Venture mRNA Manufacturing..
9/26/202316:06EDGAR2Form 8-K - Current report
9/26/202308:30BWArcturus Therapeutics and Cystic Fibrosis Foundation Extend..
9/19/202308:30BWStudy Shows Novel sa-mRNA Vaccines Offer Robust, Broad,..
9/05/202308:30BWArcturus Therapeutics and CSL Announce European Medicines..
8/17/202308:30BWArcturus Therapeutics to Attend Upcoming Investor..
8/14/202309:00BWArcturus Therapeutics Joint Venture mRNA Manufacturing..
8/07/202317:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/202316:23EDGAR2Form 8-K - Current report
8/07/202316:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
8/07/202316:01BWArcturus Therapeutics Announces Second Quarter 2023..
8/03/202316:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/03/202316:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/24/202316:01BWArcturus Therapeutics to Report Second Quarter 2023..
7/14/202307:53EDGAR2Form 8-K - Current report
6/30/202308:28EDGAR2Form 8-K - Current report
6/01/202308:30BWArcturus Therapeutics Receives U.S. FDA Fast Track..
5/09/202316:01BWArcturus Therapeutics Announces First Quarter 2023 Financial..
4/26/202308:30BWArcturus Therapeutics to Report First Quarter Financial..

Your Recent History

Delayed Upgrade Clock